Filing Details
- Accession Number:
- 0001555280-21-000235
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2021-05-21 16:41:51
- Reporting Period:
- 2021-05-19
- Accepted Time:
- 2021-05-21 16:41:51
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1555280 | Zoetis Inc. | ZTS | Pharmaceutical Preparations (2834) | 460696167 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1567878 | Roxanne Lagano | C/O Zoetis Inc. 10 Sylvan Way Parsippany NJ 07054 | Executive Vice President | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2021-05-19 | 1,362 | $41.83 | 43,445 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2021-05-19 | 4,638 | $55.02 | 48,083 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2021-05-19 | 6,000 | $169.05 | 42,083 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option | Disposition | 2021-05-19 | 1,362 | $0.00 | 1,362 | $0.00 |
| Common Stock | Stock Option | Disposition | 2021-05-19 | 4,638 | $0.00 | 4,638 | $0.00 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 58,342 | No | 4 | M | Direct | ||
| 53,704 | No | 4 | M | Direct |
Footnotes
- The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 29, 2020.
- The Price reported in Table I, Column 4 is the price at which these shares were sold in multiple transactions.
- Stock options (right to buy Zoetis Inc. common stock) granted pursuant to the Zoetis Inc. 2013 Equity and Incentive Plan. The options vest on the third anniversary of the date of grant.
- 1,362 options granted February 19, 2016 at an exercise price of $41.83 per option.
- Each option vests on the third anniversary of the date of grant.
- Each option expires on the tenth anniversary of the date of grant.
- 17,482 options granted February 14, 2017 at an exercise price of $55.02 per option; 13,964 options granted February 13, 2018 at an exercise price of $73.24 per option; 12,052 options granted February 12, 2019 at an exercise price of $87.51 per option; 7,738 options granted February 11, 2020 at an exercise price of $144.03 per option; and 7,106 options granted February 10, 2021 at an exercise price of $160.62 per option.
- 4,638 options granted February 14, 2017 at an exercise price of $55.02 per option.
- 12,844 options granted February 14, 2017 at an exercise price of $55.02 per option; 13,964 options granted February 13, 2018 at an exercise price of $73.24 per option; 12,052 options granted February 12, 2019 at an exercise price of $87.51 per option; 7,738 options granted February 11, 2020 at an exercise price of $144.03 per option; and 7,106 options granted February 10, 2021 at an exercise price of $160.62 per option.
Billionaire Hedge Funds
